Marty Makary is out, and the Trump administration has a long wish list for its next FDA commissioner.

His tenure was marked by organizational upheaval, controversies over drug approvals and tensions with the White House.

Marty Makary resigned as FDA commissioner Tuesday. The next commissioner will inherit the same punishing contradictions, and a weaker, politicized agency.

Leaders want the next FDA commissioner to be someone who can rebuild trust, focus on food policy, and drive drug-approval reforms.

They called for stability and predictability at the agency at Axios' Future of Health summit.

Marty Makary is out, and experts are calling for a return to order

With the FDA now rudderless following the revelation that commissioner Marty Makary, M.D., is stepping down, voices across biopharma have joined in support of the FDA’s former top…

Marty Makary is out, and the Trump administration has a long wish list for its next FDA commissioner.